Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Munsch Frederick

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/1/2021

3. Issuer Name and Ticker or Trading Symbol

Bausch Health Companies Inc. [BHC]

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
SVP, Controller and CAO /

(Street)

BRIDGEWATER, NJ 08807

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, No Par Value	21172 ⁽¹⁾⁽²⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Qualified Stock Options (right to purchase)	⁽³⁾	3/1/2027	Common Shares, No Par Value	8046	$14.38	D
Non-Qualified Stock Options (right to purchase)	⁽³⁾	3/7/2028	Common Shares, No Par Value	12172	$15.32	D
Non-Qualified Stock Options (right to purchase)	⁽³⁾	2/27/2029	Common Shares, No Par Value	8506	$23.16	D
Non-Qualified Stock Options (right to purchase)	⁽³⁾	2/26/2030	Common Shares, No Par Value	11265	$24.77	D
Non-Qualified Stock Options (right to purchase)	⁽³⁾	3/3/2031	Common Shares, No Par Value	6683	$32.56	D

Explanation of Responses:
(1)	Includes 14,616 Restricted Share Units ("RSUs") which will vest, subject to the reporting person's continued service, as follows: (i) 891 RSUs on February 26, 2022; (ii) 974 RSUs on February 27, 2022; (iii) 892 RSUs on February 26, 2023; (iv) 5,322 RSUs granted on March 3, 2021 that will vest in equal installments on each of the first three anniversaries of the date of grant; and (v) 6,537 RSUs granted on May 3, 2021 that will vest in equal in equal installments on each of the first three anniversaries of the date of grant.
(2)	Vested RSUs are settled in Common Shares, no par value, of the Issuer.
(3)	Vests in equal installments on each of the first three anniversaries of the date of grant.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Munsch Frederick 400 SOMERSET CORPORATE BLVD. BRIDGEWATER, NJ 08807			SVP, Controller and CAO